ZVR 300 Pill - white round
Pill with imprint ZVR 300 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Cipla Ltd.
Zidovudine is used in the treatment of Reduction of Perinatal Transmission of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZVR 300
Zidovudine
- Imprint
- ZVR 300
- Strength
- 300 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla Ltd.
- National Drug Code (NDC)
- 53104-0101
- Inactive Ingredients
-
sodium starch glycolate type A potato,
microcrystalline cellulose,
corn starch,
magnesium silicate,
magnesium stearate,
hypromelloses,
silicon dioxide
Note: Inactive ingredients may vary.
More about zidovudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
- Zidovudine oral/injection drug information
- Zidovudine (Intravenous) (Advanced Reading)
- Zidovudine (Oral) (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Syrup
Other brands
Professional resources
- Zidovudine monograph
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Syrup (FDA)
- Zidovudine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
